Metformin reduces ovarian hyperstimulation syndrome risk in polycystic ovary syndrome patients who receive gonadotropins for in-vitro fertilization cycles. A parallel randomized double-blind placebo-controlled clinical trial / Palomba, S., Falbo, A., Di Cello, A., Cappiello, F., Tolino, A., La Sala, G.B., Zullo, F., Cittadini, E.. - In: FERTILITY AND STERILITY. - ISSN 0015-0282. - STAMPA. - 96:6(2011), pp. 1384-1390.
Metformin reduces ovarian hyperstimulation syndrome risk in polycystic ovary syndrome patients who receive gonadotropins for in-vitro fertilization cycles. A parallel randomized double-blind placebo-controlled clinical trial.
TOLINO, ACHILLE;
2011
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
